<DOC>
	<DOCNO>NCT00403962</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety tolerability combination Vestipitant Paroxetine patient Social Anxiety Disorder ( SAD )</brief_summary>
	<brief_title>A Combination Therapy In Patients With Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Vestipitant</mesh_term>
	<criteria>Inclusion criterion : Primary diagnosis Generalised Social Anxiety Disorder define DSMIV . Capable give informed consent willing comply study requirement . Women childbearing potential must agree one number define acceptable method birth control . Exclusion criterion : Primary diagnosis within past 6 month another Axis 1 disorder Major Depression another anxiety disorder . Use medication psychiatric condition include herbal past 212 week accord medication type . Subjects , investigator 's judgement pose current , serious suicidal homicidal risk make suicide attempt within past 6 month . Subjects currently meet meet within 6 month prior screen DSMIV criterion substance abuse subject currently meet meet within 6 month prior screen DSMIV criterion substance dependence ( nicotine ) . Significantly abnormal blood urine laboratory test electrocardiogram ( ECG ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>anxiety</keyword>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>SAD</keyword>
</DOC>